GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Stevanato Group S.p.A.
Stevanato Group is a leading manufacturer of glass packaging (vials, syringes) for the pharmaceutical industry. Its share price reflects the growing global market for injectables, vaccines, and biopharmaceuticals, which require high-quality, sterile packaging.
Share prices of companies in the market segment - Medical instruments
Stevanato Group is a leader in glass packaging for the pharmaceutical industry. We classify it as part of the Medical Instruments sector. The graph below shows the dynamics of this segment, driven by the growth of the injectables and vaccines market.
Broad Market Index - GURU.Markets
Stevanato Group is a leading global manufacturer of glass containers (vials, syringes) and comprehensive solutions for the pharmaceutical industry. Its key role in the sector earns it a spot in the GURU.Markets index. The chart below compares its performance with the market.
Change in the price of a company, segment, and market as a whole per day
STVN - Daily change in the company's share price Stevanato Group S.p.A.
For Stevanato Group, a manufacturer of pharmaceutical packaging (vials and syringes), daily price changes reflect sensitivity to drug and vaccine production volumes. This volatility is an important component of complex models at System.GURU.Markets, which analyze the entire pharmaceutical supply chain.
Daily change in the price of a set of shares in a market segment - Medical instruments
Stevanato Group S.p.A. is a leading manufacturer of glass packaging for the pharmaceutical industry. This chart shows the average daily volatility of the sector. Comparison with the dynamics of STVN, a key supplier of injectables, helps assess its stability.
Daily change in the price of a broad market stock, index - GURU.Markets
Stevanato Group is a leading manufacturer of glass containers and drug delivery systems for the pharmaceutical industry. Its business is closely linked to the healthcare industry. The chart below illustrates the overall market volatility, which may make Stevanato appear more secure.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Stevanato Group S.p.A.
Stevanato Group is an Italian company and a leader in the production of glass pharmaceutical packaging (vials, syringes). Its annual growth reflects the stable demand from the pharmaceutical industry. The chart below tells the story of its indispensable role.
Annual dynamics of market capitalization of the market segment - Medical instruments
Stevanato Group S.p.A. is a leading manufacturer of glass packaging and drug delivery systems for the pharmaceutical industry. Its products are critical for the production of vaccines and injectables. The chart shows how its key role in this ecosystem enables its accelerated growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Stevanato Group, a manufacturer of glass containers for the pharmaceutical industry, is a gold mine for the healthcare industry. Demand for its products is stable and unaffected by economic cycles. The company's share price reflects sustained growth fueled by global demand for medicines and vaccines, making it a safe haven asset.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Stevanato Group S.p.A.
Stevanato Group, a key supplier of glass packaging and equipment for the pharmaceutical industry. The monthly fluctuations on the chart reflect demand for vials and syringes, particularly for complex biotech drugs and vaccines, making the company a vital link in the pharmaceutical supply chain.
Monthly dynamics of market capitalization of the market segment - Medical instruments
This chart illustrates the dynamics of the pharmaceutical packaging sector. For Stevanato, one of the leaders, this provides context. Its movements reflect demand for its high-quality glass vials and syringes from pharmaceutical and biotech companies.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Stevanato Group is a leading global manufacturer of glass containers (vials, syringes) and equipment for the pharmaceutical industry. These products are a critical component in the production of injectable medications. The chart below shows the overall market sentiment. Stevanato's performance is supported by the stable growth of the pharmaceutical market, which gives it a protective edge.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Stevanato Group S.p.A.
Shares of Stevanato Group, a manufacturer of glass packaging for the pharmaceutical industry, are responding to news from the world of biotech and pharmaceuticals. Weekly performance reflects demand for vials and syringes, particularly in light of the development and distribution of new injectables.
Weekly dynamics of market capitalization of the market segment - Medical instruments
Stevanato Group, as a pharmaceutical packaging manufacturer, is dependent on overall sector trends. The growth of the injectables and vaccines market creates a common demand for all vial and syringe suppliers. The chart below shows how STVN's performance aligns with the overall growth of the biopharmaceutical market it serves.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Stevanato Group, as a key supplier to the pharmaceutical industry, can demonstrate defensive qualities. Demand for its glass pharmaceutical packaging is weakly dependent on the economic situation, which may make its shares more stable than the overall market. The chart will help assess whether STVN truly is a safe haven during periods of general market turbulence.
Market capitalization of the company, segment and market as a whole
STVN - Market capitalization of the company Stevanato Group S.p.A.
The Stevanato Group market capitalization chart reflects the behind-the-scenes side of the pharmaceutical industry. The company produces glass vials, syringes, and drug delivery systems. Its market price dynamics reflect the market's perception of demand for high-quality packaging for injectables, particularly for complex biological drugs.
STVN - Share of the company's market capitalization Stevanato Group S.p.A. within the market segment - Medical instruments
Stevanato Group is a key supplier of glass containers (vials, syringes) and equipment for the pharmaceutical industry. Its share of the segment's market capitalization reflects its critical role in the pharmaceutical supply chain. The chart below shows how investors view its growth, particularly in the context of vaccine and biopharmaceutical production.
Market capitalization of the market segment - Medical instruments
Stevanato Group produces glass packaging and syringes for the pharmaceutical industry, playing a key role in the supply of vaccines and drugs. The chart below shows the market capitalization of the medical instruments sector. Its valuation reflects the importance of reliable infrastructure for healthcare.
Market capitalization of all companies included in a broad market index - GURU.Markets
Stevanato Group produces glass containers and equipment for the pharmaceutical industry, including vaccine vials and syringes. The company's market capitalization reflects its critical role in the global pharmaceutical supply chain. Its market share represents the weight of the industry, which ensures the safe packaging and delivery of vital medications.
Book value capitalization of the company, segment and market as a whole
STVN - Book value capitalization of the company Stevanato Group S.p.A.
Stevanato Group's foundation is high-tech pharmaceutical manufacturing. The company's book value reflects its factories producing glass vials for vaccines, syringes, and drug delivery systems, as well as its engineering centers. The chart below tells the story of how the company became a critical link in the global healthcare supply chain.
STVN - Share of the company's book capitalization Stevanato Group S.p.A. within the market segment - Medical instruments
Stevanato Group manufactures glass pharmaceutical containers and medical devices at its own factories. These high-tech, sterile production lines are its main material asset. The S_BCap_Seg graph shows the company's control over the medical equipment infrastructure.
Market segment balance sheet capitalization - Medical instruments
The chart shows the book value of the medical instruments sector. Against this backdrop, Stevanato Group, as a manufacturer of glass packaging for medications and syringes, is a critical and capital-intensive component. Producing sterile and high-precision products requires the ownership of modern and expensive factories.
Book value of all companies included in the broad market index - GURU.Markets
Stevanato Group owns factories producing glass vials, syringes, and drug delivery systems—critical packaging for the pharmaceutical industry. Their balance sheet represents actual production capacity, creating "vessels" that save lives. Compared to the overall economics shown in the chart, Stevanato is a key link in the healthcare chain.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Stevanato Group S.p.A.
Stevanato Group's balance sheet is the value of its glass drug vial factories. Its market capitalization is a measure of its critical role in the supply chain for the entire pharmaceutical industry. The MvsBCap_Co chart shows the premium the market pays for its status as an indispensable supplier of containers for life-saving medications.
Market to book capitalization ratio in a market segment - Medical instruments
Stevanato Group produces glass containers and equipment for the pharmaceutical industry. Its business is critical to the drug supply chain. The chart shows the market premium placed on its quality, reputation, and long-term relationships with pharmaceutical giants, which are valued above simple manufacturing.
Market to book capitalization ratio for the market as a whole
Stevanato Group is a leading provider of pharmaceutical solutions, including glass vials, syringes, and manufacturing equipment. The company combines high-tech manufacturing with a critical role in the pharmaceutical supply chain. This chart provides an overview of how the market views pharmaceutical suppliers relative to overall market dynamics.
Debts of the company, segment and market as a whole
STVN - Company debts Stevanato Group S.p.A.
For Stevanato Group, a manufacturer of glass packaging for the pharmaceutical industry, debt is a tool for expanding production capacity. This chart shows how the company is investing in new factories to meet the growing demand for vials and syringes, especially since the pandemic. Debt here enables growth in an industry strategically important to healthcare.
Market segment debts - Medical instruments
Stevanato Group is a key supplier of glass containers and drug delivery systems for the pharmaceutical industry, including vaccine vials. High quality standards and growing demand require ongoing investment in production capacity. This chart shows how the company is funding its expansion to meet global healthcare needs.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Stevanato Group S.p.A.
Stevanato Group is a leading manufacturer of glass containers and drug delivery systems for the pharmaceutical industry. This chart shows how the company is funding its expansion amid growing demand for injectables. The debt level here reflects investments in the construction of new plants and the development of innovative solutions for safe drug delivery.
Market segment debt to market segment book capitalization - Medical instruments
Stevanato Group is a leading manufacturer of glass containers and drug delivery systems for the pharmaceutical industry. This chart shows the debt dynamics in the medical instruments sector, providing insight into how the company is financing the expansion of its production capacity to meet growing demand from biopharmaceutical companies.
Debt to book value of all companies in the market
Stevanato Group, a supplier to the pharmaceutical industry, relies on the growth of the biotech sector. The chart reflects the market's overall debt burden. It allows one to assess the extent to which demand for Stevanato's products and its investment policy are independent of macroeconomic cycles thanks to the stable and innovative nature of the pharmaceutical industry.
P/E of the company, segment and market as a whole
P/E - Stevanato Group S.p.A.
This metric for Stevanato Group, an Italian manufacturer of glass containers and equipment for the pharmaceutical industry, reflects the state of the global pharmaceutical market. The high P/E ratio is supported by stable demand for vials and syringes, especially in light of the growing market for injectables. Fluctuations may be due to large contracts or changes in production plans of pharmaceutical giants.
P/E of the market segment - Medical instruments
This chart shows the average P/E for medical instrument and consumables manufacturers. For Stevanato Group, as a key supplier of pharmaceutical packaging, this provides important context. Its higher P/E than the average indicates that investors value its critical role in the supply chain for the growing injectables market.
P/E of the market as a whole
Stevanato Group is a leading manufacturer of glass containers (vials, syringes) and equipment for the pharmaceutical industry. The company is a critical link in the supply chain for medicines and vaccines. This overall market sentiment chart allows you to assess how highly investors value the stability and indispensability of Stevanato's business in any economic climate.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Stevanato Group S.p.A.
Stevanato Group produces glass containers and integrated systems for the pharmaceutical industry, including vaccine vials and syringes. The company's future growth depends on the growth of the global pharmaceutical market and demand for high-quality packaging for injectables. This chart demonstrates investors' confidence in the stability of the pharmaceutical industry and Stevanato's unique position in this niche.
Future (projected) P/E of the market segment - Medical instruments
Stevanato Group is a leading Italian manufacturer of glass containers (vials, syringes) for the pharmaceutical industry and a provider of engineering solutions. The company played a key role in packaging COVID-19 vaccines. The chart shows average expectations for the sector, helping to assess how highly the market values Stevanato's position as a critical link in the pharmaceutical supply chain.
Future (projected) P/E of the market as a whole
Stevanato Group produces glass containers and integrated systems for the pharmaceutical industry. Their products are critical for the storage and administration of medications. Overall market optimism, as reflected in the chart, supports investment in biotechnology and pharmaceuticals. This provides Stevanato with stable demand from developers of new vaccines, insulins, and biologics.
Profit of the company, segment and market as a whole
Company profit Stevanato Group S.p.A.
Stevanato Group specializes in the production of glass packaging (vials, syringes) for the pharmaceutical industry and provides engineering solutions. This chart reflects stable demand from the pharmaceutical sector. The company's profits are growing in line with global drug and vaccine production, making it a key link in the healthcare supply chain.
Profit of companies in the market segment - Medical instruments
Stevanato Group S.p.A. produces glass containers (vials, syringes) and equipment for the pharmaceutical industry. The company's profitability is directly dependent on the growth of the global pharmaceutical market and demand for injectables. This chart illustrates the steady growth in the medical supplies sector, fueled by the ongoing demand for high-quality pharmaceutical packaging.
Overall market profit
Stevanato Group is a leading manufacturer of glass containers (vials, syringes) for the pharmaceutical industry. The company plays a critical role in the pharmaceutical supply chain. Demand for its products is stable and growing alongside advances in biotechnology, making its business resilient to economic cycles, as illustrated in this chart.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Stevanato Group S.p.A.
Stevanato Group is a leading manufacturer of glass containers (vials, syringes) and equipment for the pharmaceutical industry. The company's profit forecast is closely tied to the health of the global pharmaceutical industry and demand for injectables. This chart shows analysts' expectations for growth in the biopharmaceutical and vaccine market, which require high-quality packaging.
Future (predicted) profit of companies in the market segment - Medical instruments
Stevanato Group is a leading manufacturer of glass containers (vials, syringes) and equipment for the pharmaceutical industry. The company plays a critical role in the supply chain for drugs and vaccines. This chart shows profitability forecasts for the medical equipment sector. It reflects overall activity in the pharmaceutical industry and demand for injectables.
Future (predicted) profit of the market as a whole
Stevanato Group produces glass containers (vials, syringes) for the pharmaceutical industry. Its business volume is directly linked to the global production of injectables. This graph, showing overall profit expectations, reflects the health of the overall economy, which allows it to finance the production and development of new drugs. Steady growth means stable demand for Stevanato products.
P/S of the company, segment and market as a whole
P/S - Stevanato Group S.p.A.
Stevanato Group is a leading manufacturer of glass containers (vials, syringes) and equipment for the pharmaceutical industry. The company's revenue is directly dependent on the production volume of drugs and vaccines. This chart shows how highly investors value its sales, betting on the growth of the global pharmaceutical market and the importance of high-quality packaging for injectables.
P/S market segment - Medical instruments
Stevanato Group S.p.A. is a leading global provider of pharmaceutical solutions, including glass primary packaging (vials, syringes) and integrated engineering systems for drug manufacturing. This chart shows the average rating for the sector, allowing one to assess how the market values Stevanato's key role in the pharmaceutical supply chain.
P/S of the market as a whole
Stevanato Group produces glass containers and integrated systems for the pharmaceutical industry, including vaccine vials and syringes. The company is a critical supplier to the biotech industry. This chart helps assess the market's willingness to value the company's revenue at the intersection of healthcare and high-tech manufacturing.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Stevanato Group S.p.A.
Stevanato Group is a leading global manufacturer of glass containers (vials, syringes) for the pharmaceutical industry. This chart reflects market expectations for the company's future sales. These trends are closely linked to the growth of the global pharmaceutical market, particularly in the injectables and vaccines segments, where Stevanato's products are critical.
Future (projected) P/S of the market segment - Medical instruments
Stevanato Group is a key supplier to the pharmaceutical industry, producing glass vials, syringes, and drug delivery systems. This chart compares the company's estimated future sales with its industry. It helps understand how highly the market values Stevanato's role in the biologics and vaccine supply chain and whether it expects continued growth in this area.
Future (projected) P/S of the market as a whole
Investor optimism about future revenues hinges on innovations in pharmaceutical packaging and drug delivery. Stevanato Group, which produces glass vials, syringes, and drug delivery systems, plays a critical role. Demand for its products, particularly for new injectables and vaccines, reflects the growth and development of the entire pharmaceutical industry.
Sales of the company, segment and market as a whole
Company sales Stevanato Group S.p.A.
Stevanato Group is a key supplier of glass packaging and drug delivery systems for the pharmaceutical industry. The company's revenue is generated by sales of vials, syringes, and injection equipment. This chart reflects the growth of the global pharmaceutical market and the increasing demand for high-quality packaging and drug delivery solutions.
Sales of companies in the market segment - Medical instruments
Stevanato Group is a key supplier to the pharmaceutical industry, producing glass vials, syringes, cartridges, and filling and packaging equipment. This chart shows total revenue in the medical instruments sector. It reflects the dynamics of injectables and vaccine production, which directly impacts demand for Stevanato products.
Overall market sales
Stevanato Group is an Italian company and a key supplier of glass containers (vials, syringes) and equipment for the pharmaceutical industry. Its business is directly linked to global drug and vaccine production volumes. This chart of the overall economic situation indirectly reflects the state of global healthcare and demand for pharmaceutical products.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Stevanato Group S.p.A.
Stevanato Group produces glass packaging (vials, syringes) and equipment for the pharmaceutical industry. Demand for its products is closely tied to the production of injectables and vaccines. The chart shows analyst revenue forecasts, reflecting their expectations for biopharmaceutical market growth and drug production volumes.
Future (projected) sales of companies in the market segment - Medical instruments
Stevanato Group is a leading supplier of glass containers (vials, syringes) and integrated solutions for the pharmaceutical industry. Demand for the company's products is directly linked to the production of injectables and vaccines. This chart shows projected sales for the entire medical instruments sector, reflecting overall growth expectations for the pharmaceutical and biotechnology markets.
Future (projected) sales of the market as a whole
Stevanato Group produces glass containers and integrated solutions for the pharmaceutical industry, including syringes and vaccine vials. Demand for the company's products is directly dependent on the production volumes of pharmaceuticals and biotech drugs. This graph reflects the overall economic situation, which impacts healthcare costs and, consequently, Stevanato's capacity utilization.
Marginality of the company, segment and market as a whole
Company marginality Stevanato Group S.p.A.
Stevanato Group is a key supplier of glass packaging and drug delivery systems for the pharmaceutical industry. This metric reflects its important role in the healthcare supply chain. It shows the percentage of revenue from vials, syringes, and equipment the company converts into net profit, demonstrating the high quality and demand for its products.
Market segment marginality - Medical instruments
Stevanato Group is a key supplier of glass containers and drug delivery systems for the pharmaceutical industry. Highest quality standards and reliability are the foundation of its business. This chart compares the company's operational efficiency with other medical component manufacturers, reflecting its strong market position and ability to produce high-value-added products.
Market marginality as a whole
Stevanato Group is a leading manufacturer of glass containers (vials, syringes) for the pharmaceutical industry and a provider of engineering solutions. Their business is closely tied to the health of the pharmaceutical sector. This overall economic profitability curve affects them indirectly, through the budgets of their pharmaceutical clients and the production volumes of injectables.
Employees in the company, segment and market as a whole
Number of employees in the company Stevanato Group S.p.A.
Stevanato Group is a key supplier of glass containers (vials, syringes) and equipment for the pharmaceutical industry. This chart reflects the state of global healthcare. The growth in staff is directly related to the increasing demand for injectables, vaccines, and biotech drugs, which require high-quality packaging.
Share of the company's employees Stevanato Group S.p.A. within the market segment - Medical instruments
Stevanato Group produces glass containers and equipment for the pharmaceutical industry. This chart shows the company's concentration of expertise in this narrow and critical niche. Its team ensures the creation of reliable solutions for the storage and administration of vaccines and medications, directly impacting global health.
Number of employees in the market segment - Medical instruments
Stevanato Group S.p.A. is a leading manufacturer of glass containers (vials, syringes) and equipment for the pharmaceutical industry. This chart shows overall employment in the medical instruments sector. Its growth reflects the expansion of drug and vaccine production worldwide, which directly increases demand for Stevanato's high-quality packaging.
Number of employees in the market as a whole
Stevanato Group is an Italian manufacturer of glass containers and equipment for the pharmaceutical industry, including vaccine vials. The growth in personnel in this chart is directly related to the increasing global demand for injectables. The company is expanding its production capacity and hiring specialists to meet the needs of Big Pharma.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Stevanato Group S.p.A. (STVN)
Stevanato Group produces glass packaging for the pharmaceutical industry (vials, syringes). This chart reflects the capital intensity of high-precision production. The company invests in sophisticated automated production lines. The high capital expenditure per employee is a result of the combination of the cost of this equipment and the strictest quality standards.
Market capitalization per employee (in thousands of dollars) in the market segment - Medical instruments
Stevanato Group is an Italian company that produces glass containers (vials, syringes) for the pharmaceutical industry and equipment for their production. This high-precision production facility caters to big pharma. This indicator, compared to the industry average, reflects how the market values their quality and technology per employee.
Market capitalization per employee (in thousands of dollars) for the overall market
Stevanato Group S.p.A. produces glass containers and equipment for the pharmaceutical industry (e.g., vaccine vials). This high-tech facility has strict quality standards. The employee rating reflects the value of precision, reliability, and innovation in this critical healthcare sector, where every employee contributes to patient safety.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Stevanato Group S.p.A. (STVN)
Stevanato Group is an Italian company that produces critical pharmaceutical components: glass vials, syringes, and filling equipment. This high-precision manufacturing process is essential. This chart shows how efficiently the company produces these vital, yet high-volume, products, measuring the net profit per employee.
Profit per employee (in thousands of dollars) in the market segment - Medical instruments
Stevanato Group (STVN) is a B2B manufacturer of pharmaceutical packaging (glass vials, syringes, cartridges). This chart shows the benchmark for "Medical Instruments" (Packaging). In this "critical" B2B sector, labor profitability is high. It's a "sticky" business, as their products are part of an FDA-approved process.
Profit per employee (in thousands of dollars) for the market as a whole
Stevanato Group (STVN) is an Italian company that produces critical pharmaceutical components: glass vials, syringes, cartridges, and filling equipment. This graph, showing average profit per employee, provides a benchmark. It helps assess how profitable the medical supplies sector, which requires precision and quality, is relative to its workforce.
Sales to employees of the company, segment and market as a whole
Sales per company employee Stevanato Group S.p.A. (STVN)
For Stevanato Group, a manufacturer of glass containers and equipment for the pharmaceutical industry, this chart demonstrates technological leadership. Its high revenue per employee reflects the critical importance of its products (vials, syringes) for the production of injectables and vaccines worldwide.
Sales per employee in the market segment - Medical instruments
Stevanato Group produces glass containers (vials, syringes) for the pharmaceutical industry and equipment for their production. This high-tech production facility is a leading manufacturer of glass containers. This metric reflects the average revenue per employee by segment. It helps assess how productive the Stevanato team is in providing pharmaceutical companies with critical packaging compared to competitors.
Sales per employee for the market as a whole
Stevanato Group (STVN) produces critical glass vials, syringes, and cartridges for the pharmaceutical industry. This metric reflects the efficiency of their highly automated production lines. The growth in revenue per employee demonstrates strong demand for their products (especially injectable solutions) and the company's ability to scale production without a corresponding increase in headcount.
Short shares by company, segment and market as a whole
Shares shorted by company Stevanato Group S.p.A. (STVN)
Stevanato Group produces premium glass containers (vials, syringes) and drug delivery systems for the pharmaceutical industry. The company experienced a boom during the pandemic thanks to demand for vaccine vials. This chart reflects investor bets that a post-COVID "normalization" of demand and the company's high valuation will lead to a correction in its stock price.
Shares shorted by market segment - Medical instruments
Stevanato Group (STVN) produces high-quality glass packaging (vials, syringes) and equipment for the pharmaceutical industry. These products are critical for the production of injectables. This chart shows the overall short position in the medical instruments sector. It reflects market concerns about a decline in demand for packaging after the pandemic or a slowdown in the biotech sector.
Shares shorted by the overall market
Stevanato Group (STVN) produces glass vials and drug delivery systems for the pharmaceutical industry. Their clients are biotech companies. When Short_All rises, it signals risk aversion. This pessimism dries up funding for biotech companies, meaning fewer new clinical trials and, consequently, a decline in demand for STVN's premium packaging.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Stevanato Group S.p.A. (STVN)
Stevanato Group produces glass packaging (vials, syringes) for the pharmaceutical industry. The business benefits from the growth of biotech. This chart for STVN above 70 may reflect strong demand from pharmaceutical companies. A level below 30 may be related to concerns about a slowdown in R&D or inventory issues at customers.
RSI 14 Market Segment - Medical instruments
Stevanato Group is an Italian company and a key supplier to the pharmaceutical industry. They produce glass vials, syringes, and cartridges for injectables. This indicator measures the overall momentum of the medical consumables sector and helps determine whether the entire segment is oversold following the pandemic demand for vaccine packaging.
RSI 14 for the overall market
Stevanato Group is a key manufacturer of glass pharmaceutical packaging (vials, syringes), including injection solutions (e.g., for vaccines). It's a "defensive" business, as medications are always in demand. This market turmoil has little impact on demand for its products, making the company attractive to investors in uncertain times.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast STVN (Stevanato Group S.p.A.)
Stevanato Group is a leading manufacturer of glass pharmaceutical packaging. They produce vials, syringes, and cartridges for injectables (such as vaccines or diabetes medications). This chart shows the analysts' average 12-month target, reflecting their expectations for demand for high-quality pharmaceutical packaging, especially for complex biologics.
The difference between the consensus estimate and the actual stock price STVN (Stevanato Group S.p.A.)
Stevanato Group (STVN) is an Italian company, a leading manufacturer of glass vials, syringes, and drug delivery systems for the pharmaceutical industry. This chart shows the pricing of drug packaging. It measures the gap between the price and the consensus target, reflecting the potential analysts see in the growth of biotechnology and demand for injections.
Analyst consensus forecast for stock prices by market segment - Medical instruments
Stevanato Group is an Italian company and one of the world's leading manufacturers of glass packaging for the pharmaceutical industry (vials, syringes), as well as filling equipment. This chart shows analysts' general expectations for the medical instruments sector. It reflects whether experts believe demand for pharmaceutical packaging will remain stable.
Analysts' consensus forecast for the overall market share price
Stevanato Group (STVN) is an Italian manufacturer of premium pharmaceutical packaging: glass vials, syringes, and cartridges (especially for insulin). Market expectations, as shown in this chart, have little impact on demand (medications are always in demand). However, they do influence risk appetite. During a downturn (pessimism), investors may dump dull stocks.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Stevanato Group S.p.A.
Stevanato Group is the gold standard in injectable packaging. The Italian company produces high-quality glass vials, syringes, and cartridges, as well as filling equipment. This chart is a biotech pick and shovel. Its growth is driven by the pharmaceutical industry's shift toward complex biologics (such as GLP-1), which require premium packaging.
AKIMA Market Segment Index - Medical instruments
Stevanato Group is a premium Italian (like West) supplier of packaging for injectable pharmaceuticals; the company produces glass vials, syringes, and filling equipment. This aggregated metric evaluates companies. The graph shows the sector average. This benchmark: to what extent does Stevanato's critical role (especially in biologics) differentiate it from the average competitor?
The AKIM Index for the overall market
Stevanato—the picks and shovels of the pharmaceutical industry—is an Italian manufacturer of premium glass vials, syringes, and drug delivery systems (especially for biotech). This chart, reflecting the market average, is the backdrop. It helps us assess how this protective business, growing alongside the pharmaceutical industry, fits into the overall macroeconomic picture.